Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study-Reference-Cited by-同舟云学术

Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study

Published:2019-01-29 Issue:4 Volume:39 Page:355-362
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Molteni Mauro^ORCID,Crippa Matteo,Orenti Annalisa,Polo Friz Hernan,Menghini Anna,Tramacere Pierluigi,Marano Giuseppe,Cimminiello Claudio,Boracchi Patrizia

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-018-0742-1.pdf

Reference34 articles.

1. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131:492–501.

2. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet. 2014;383:955–62.

3. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, Moomaw CJ, Haverbusch M, Broderick JP. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116–21.

4. Verhagen H. Local hemorrhage and necrosis of the skin and underlying tissues at starting therapy with dicumarol or dicumacyl. Acta Med Scand. 1954;148:453–67.

5. Raj K, Collins B, Rangarajan S. Purple toe syndrome following anticoagulant therapy. Br J Haematol. 2001;114:740.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta‐analysis of dabigatran peak and trough concentration in adults;British Journal of Clinical Pharmacology;2022-06-16

2. The connubium among diabetes, chronic kidney disease and atrial fibrillation;Minerva Cardiology and Angiology;2022-05

3. Impact of Renal Function on Effectiveness and Safety Associated With Low Dose Dabigatran in Non-valve Atrial Fibrillation Patients After Catheter Ablation;Frontiers in Cardiovascular Medicine;2021-10-28

4. Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran;Rational Pharmacotherapy in Cardiology;2021-05-07